Catheter Ablation for Ventricular Arrhythmias in Hypertrophic Cardiomyopathy

Subramanian, Muthiah; Atreya, Auras R.; Yalagudri, Sachin; Shekar, P. Vijay; Saggu, Daljeet Kaur; Narasimhan, Calambur

doi:10.1016/j.ccep.2022.08.005

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Indications for catheter ablation for VAs in patients with HCM are not clearly defined and need to be tailored for each patient. 12 Santangeli and colleagues found that epicardial ablation was necessary to treat VT in close to 60% of cases. 13 Therefore, understanding the location and extent of the substrate can help in guiding the ablation strategy.…”

Section: Discussionmentioning

confidence: 99%

Simultaneous Ablation of Ventricular Tachycardia and Hemodynamic Improvement of Mid-ventricular Obstructive Hypertrophic Cardiomyopathy by Coronary Venous Ethanol Ablation

TOPALOGLU,

VURGUN,

KORKMAZ

et al. 2024

J Innov Cardiac Rhythm Manage.

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Simultaneous Ablation of Ventricular Tachycardia and Hemodynamic Improvement of Mid-ventricular Obstructive Hypertrophic Cardiomyopathy by Coronary Venous Ethanol Ablation

TOPALOGLU,

VURGUN,

KORKMAZ

et al. 2024

J Innov Cardiac Rhythm Manage.

View full text Add to dashboard Cite

Apical hypertrophic cardiomyopathy: pathophysiology, diagnosis and management

Li,

Fang,

Liu

et al. 2023

Clin Res Cardiol

View full text Add to dashboard Cite

Since the first description of apical hypertrophic cardiomyopathy (ApHCM) in 1976, contrasting information from all over the world has emerged regarding the natural history of the disease. However, the recommended guidelines on hypertrophic cardiomyopathy (HCM) pay a cursory reference to ApHCM, without ApHCM-specific recommendations to guide the diagnosis and management. In addition, cardiologists may not be aware of certain aspects that are specific to this disease subtype, and a robust understanding of specific disease features can facilitate recognition and timely diagnosis. Therefore, the review covers the incidence, pathogenesis, and characteristics of ApHCM and imaging methods. Echocardiography and cardiovascular magnetic resonance imaging (CMR) are the most commonly used imaging methods. Moreover, this review presents the management strategies of this heterogeneous clinical entity. In this review, we introduce a novel transapical beating-heart septal myectomy procedure for ApHCM patients with a promising short-time result. Graphical abstract

show abstract

Catheter Ablation for Ventricular Arrhythmias in Hypertrophic Cardiomyopathy

Cited by 2 publications

References 27 publications

Simultaneous Ablation of Ventricular Tachycardia and Hemodynamic Improvement of Mid-ventricular Obstructive Hypertrophic Cardiomyopathy by Coronary Venous Ethanol Ablation

Simultaneous Ablation of Ventricular Tachycardia and Hemodynamic Improvement of Mid-ventricular Obstructive Hypertrophic Cardiomyopathy by Coronary Venous Ethanol Ablation

Apical hypertrophic cardiomyopathy: pathophysiology, diagnosis and management

Contact Info

Product

Resources

About